Shanghai MicroPort MedBot (Group) Co., Ltd.
HKEX:2252.HK
9.24 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 49.619 | 49.619 | 28.495 | 28.495 | 23.802 | 23.802 | 10.278 | 10.278 | 0.524 | 0.524 | 1.075 | 1.075 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 26.112 | 26.112 | 32.182 | 32.182 | 12.768 | 12.768 | 7.342 | 7.342 | 0.179 | 0.179 | 0.616 | 0.616 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 23.507 | 23.507 | -3.687 | -3.687 | 11.034 | 11.034 | 2.936 | 2.936 | 0.346 | 0.346 | 0.46 | 0.46 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.474 | 0.474 | -0.129 | -0.129 | 0.464 | 0.464 | 0.286 | 0.286 | 0.659 | 0.659 | 0.427 | 0.427 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 82.075 | 82.075 | 128.739 | 128.739 | 155.848 | 155.848 | 209.696 | 209.696 | 168.206 | 168.206 | 116.289 | 116.289 | 80.036 | 80.036 | 47.418 | 47.418 | 20.272 | 20.272 |
| General & Administrative Expenses
| 15.036 | 15.036 | 24.382 | 24.382 | 38.799 | 38.799 | 52.667 | 52.667 | 32.569 | 32.569 | 27.503 | 27.503 | 26.236 | 26.236 | 9.844 | 9.844 | 3.599 | 3.599 |
| Selling & Marketing Expenses
| 46.112 | 46.112 | 55.761 | 55.761 | 63.454 | 63.454 | 59.941 | 59.941 | 32.08 | 32.08 | 32.266 | 32.266 | 7.329 | 7.329 | 0.916 | 0.916 | 0.431 | 0.431 |
| SG&A
| 61.148 | 61.148 | 80.143 | 80.143 | 102.252 | 102.252 | 112.608 | 112.608 | 64.65 | 64.65 | 59.769 | 59.769 | 33.564 | 33.564 | 10.268 | 10.268 | 4.521 | 4.521 |
| Other Expenses
| 2.573 | 2.573 | 15.369 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 145.795 | 145.795 | 224.251 | 233.089 | 281.256 | 281.256 | 346.674 | 346.674 | 237.513 | 237.513 | 173.964 | 173.964 | 127.139 | 127.139 | 59.704 | 59.704 | 24.421 | 24.421 |
| Operating Income
| -122.288 | -122.288 | -227.938 | -208.309 | -242.308 | -242.308 | -315.93 | -315.93 | -232.556 | -232.556 | -171.43 | -171.43 | -113.396 | -113.396 | -56.875 | -56.875 | -24.42 | -24.42 |
| Operating Income Ratio
| -2.465 | -2.465 | -7.999 | -7.31 | -10.18 | -10.18 | -30.74 | -30.74 | -443.808 | -443.808 | -159.469 | -159.469 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -17.687 | -17.687 | -11.461 | -31.09 | -30.059 | -30.059 | -25.462 | -25.462 | 0.805 | 0.805 | 0.456 | 0.456 | -7.884 | -7.884 | -23.287 | -23.287 | -0.063 | -0.063 |
| Income Before Tax
| -139.975 | -139.975 | -239.399 | -239.399 | -272.367 | -272.367 | -341.392 | -341.392 | -231.751 | -231.751 | -170.974 | -170.974 | -121.28 | -121.28 | -80.162 | -80.162 | -24.483 | -24.483 |
| Income Before Tax Ratio
| -2.821 | -2.821 | -8.402 | -8.402 | -11.443 | -11.443 | -33.217 | -33.217 | -442.272 | -442.272 | -159.045 | -159.045 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 4.325 | 4.325 | -2.818 | -2.818 | -2.861 | -2.861 | -1.015 | -1.015 | -2.225 | -2.225 | -0.496 | -0.496 | -0.298 | -0.298 | -3.196 | -3.196 | 0 | 0 |
| Net Income
| -138.581 | -138.581 | -236.581 | -236.581 | -269.506 | -269.506 | -340.377 | -340.377 | -229.526 | -229.526 | -170.478 | -170.478 | -120.983 | -120.983 | -76.966 | -76.966 | -24.483 | -24.483 |
| Net Income Ratio
| -2.793 | -2.793 | -8.303 | -8.303 | -11.323 | -11.323 | -33.119 | -33.119 | -438.027 | -438.027 | -158.584 | -158.584 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.14 | -0.14 | -0.25 | -0.25 | -0.28 | -0.28 | -0.36 | -0.36 | -0.24 | -0.24 | -0.18 | -0.18 | -0.13 | -0.13 | -0.096 | -0.096 | -0.035 | -0.035 |
| EPS Diluted
| -0.14 | -0.14 | -0.25 | -0.25 | -0.28 | -0.28 | -0.36 | -0.36 | -0.24 | -0.24 | -0.18 | -0.18 | -0.13 | -0.13 | -0.096 | -0.096 | -0.035 | -0.035 |
| EBITDA
| -95.89 | -95.89 | -195.314 | -195.314 | -224.785 | -224.785 | -303.911 | -303.911 | -223.333 | -223.333 | -168.825 | -168.825 | -112.427 | -112.427 | -56.357 | -56.357 | -24.106 | -24.106 |
| EBITDA Ratio
| -1.933 | -1.933 | -6.854 | -6.854 | -9.444 | -9.444 | -29.571 | -29.571 | -426.208 | -426.208 | -157.047 | -157.047 | 0 | 0 | 0 | 0 | 0 | 0 |